Dementia patients treated with neuroleptic drugs instead of anti-dementia medication: Study

Demented patients are often treated nonspecifically with psychoactive medications. Neuroleptic drugs are given even when they are not specifically indicated, as Tomislav Majic and his colleagues from the Charité Hospital, Berlin, show in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[18]: 320-7).

As dementia worsens, neuropsychiatric symptoms such as depression, apathy, and aggressiveness become more common. These cause suffering, not just for the patient, but also for the nursing staff and for the patient's fellow elderly home residents. In this cross-sectional study, the authors analyzed data on 304 demented patients from 18 homes for the elderly in Berlin. More than half of them were being treated with neuroleptic drugs; on the other hand, anti-dementia drugs were only rarely prescribed, despite evidence of their effectiveness in severe dementia.

Psychoactive drugs can have serious side effects that increase the risk of death. The authors recommend, therefore, that they be used with specific goals in mind, in accordance with existing guidelines. Other, complementary therapies, not necessarily pharmacological, should also be considered.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New neuroimaging marker may identify persons at risk of dementia in future clinical trials